Experience with dexmetomidine in the management of alcohol withdrawal syndrome for patients with cirrhosis

Introduction and Objectives: Lorazepam is the first-line treatment in patients with alcohol withdrawal syndrome (AWS). In patients with cirrhosis and AWS, the use of dexmetomidine (DXM) has been poorly studied. The objective of this study is to report the effect of DXM in patients with cirrhosis and...

Full description

Saved in:
Bibliographic Details
Main Authors: Liliana I. Gallardo-González, Jose L. Perez-Hernandez, Maria F. Higuera-De la, Tijera, Mary C. Alegría-Ovando
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268125000195
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items